FDA Commissioner Scott Gottlieb has been very public in expressing his desire to provide increased competition and greater choice to American consumers in a bid to drive down prices of prescription medicines. Recently, the agency he oversees took some unusual steps to back up those statements with action. Last week, the FDA approved the use … Continue reading “On Drug Pricing: FDA Backs Up Its Calls for Increased Competition”
Author: Troy Wilson
Troy Wilson currently serves as president and CEO of Kura Oncology. He has served as president and CEO of Wellspring Biosciences and its parent company Araxes Pharma LLC since July 2012 and as president and CEO of Avidity NanoMedicines since November 2012. Previously, Wilson served as the president, CEO and a board member of Intellikine, until its acquisition by Takeda Pharmaceuticals in 2011. He is a member of the board of directors of Kura Oncology, Puma Biotechnology and Zosano Pharma. Wilson holds a law degree from New York University and graduated with a doctorate in bioorganic chemistry and a B.A. in biophysics from the University of California, Berkeley.
Glaxo and J&J’s Shrewd Move Will Help the Biotech Ecosystem
Index Ventures made news recently when it announced a new €150 million fund to invest in early-stage, life science companies. With many venture firms scaling back or exiting the business entirely, any successful fundraising is good news. However, two aspects made the announcement from Index particularly noteworthy: first, the fund is focused on early-stage innovation, … Continue reading “Glaxo and J&J’s Shrewd Move Will Help the Biotech Ecosystem”
Testing Experimental Drugs in Combination – A New Trend
Sanofi-Aventis and Merck KGaA announced recently they are teaming up to test new cancer drugs in combination, joining a growing trend among drug makers to combine different cancer therapies in early-stage clinical studies. Combinations of different drugs are used frequently in the treatment of cancer, but such regimens are normally developed only after medicines reach … Continue reading “Testing Experimental Drugs in Combination – A New Trend”